92 related articles for article (PubMed ID: 2974263)
21. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM; Boulet LP; Follows RM
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[TBL] [Abstract][Full Text] [Related]
22. Prolonged bronchodilating effect of formoterol versus procaterol in bronchial asthma.
Chetta A; Del Donno M; Maiocchi G; Pisi G; Moretti D; Olivieri D
Ann Allergy; 1993 Feb; 70(2):171-4. PubMed ID: 8430925
[TBL] [Abstract][Full Text] [Related]
23. Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma.
Nelson HS; Berkowitz RB; Tinkelman DA; Emmett AH; Rickard KA; Yancey SW
Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1556-61. PubMed ID: 10228126
[TBL] [Abstract][Full Text] [Related]
24. A new bronchodilating agent, procaterol, in preventing exercise-induced asthma.
Ioli F; Donner CF; Fracchia C; Manini G; Patessio A; Spada EL; Vecchio C
Int J Clin Pharmacol Res; 1986; 6(5):389-96. PubMed ID: 2946644
[TBL] [Abstract][Full Text] [Related]
25. Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.
Wenzel SE; Lumry W; Manning M; Kalberg C; Cox F; Emmett A; Rickard K
Ann Allergy Asthma Immunol; 1998 Jun; 80(6):463-70. PubMed ID: 9647268
[TBL] [Abstract][Full Text] [Related]
26. A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction.
Baronti A; Grieco A; Vibelli C
Eur J Respir Dis; 1980 Jun; 61(3):143-50. PubMed ID: 7002574
[TBL] [Abstract][Full Text] [Related]
27. Extended-release albuterol in the treatment of 6- to 12-year-old asthmatic children.
Skoner DP; Boltansky H; Kobayashi RH; Pearlman DS; Shapiro G; Harrison JE; Trochelmann LM; Lorber RR
Ann Allergy Asthma Immunol; 1996 May; 76(5):462-8. PubMed ID: 8630721
[TBL] [Abstract][Full Text] [Related]
28. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol.
Milgrom H; Skoner DP; Bensch G; Kim KT; Claus R; Baumgartner RA;
J Allergy Clin Immunol; 2001 Dec; 108(6):938-45. PubMed ID: 11742271
[TBL] [Abstract][Full Text] [Related]
29. Fluticasone/Formoterol combination therapy compared with monotherapy in adolescent and adult patients with mild to moderate asthma.
Pearlman DS; LaForce CF; Kaiser K
Clin Ther; 2013 Jul; 35(7):950-66. PubMed ID: 23870606
[TBL] [Abstract][Full Text] [Related]
30. Prednisolone oral solution plus inhaled procaterol for acute asthma in children: a double-blind randomized controlled trial.
Huang LH; Shyur SD; Wen DC; Chang YC; Ma YC; Lin SC; Wu WC; Wu JY
Acta Paediatr Taiwan; 2007; 48(5):257-62. PubMed ID: 18254574
[TBL] [Abstract][Full Text] [Related]
31. [Clinical evaluation of procaterol and salbutamol in patients with bronchial asthma].
Płusa T; Zaraś E; Kruszewski J
Pneumonol Alergol Pol; 1992; 60(11-12):48-52. PubMed ID: 1303778
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and duration of action of procaterol, a new bronchodilator.
Zanetti CL; Rotman HH; Dresner AJ
J Clin Pharmacol; 1982; 22(5-6):250-3. PubMed ID: 6213680
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of procaterol aerosol as an aerosolized beta 2-adrenergic bronchodilator in conscious guinea pigs].
Arai Y; Nitta K; Shida T
Arerugi; 1985 Nov; 34(11):999-1005. PubMed ID: 2867754
[No Abstract] [Full Text] [Related]
34. Efficacy and duration of action of oral procaterol in asthmatic children after single administration of different dosages.
Boner AL; Zanotto CE; Piacentini G; Miglioranzi P; Richelli C; Sette L
J Asthma; 1990; 27(1):21-30. PubMed ID: 2137815
[TBL] [Abstract][Full Text] [Related]
35. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
[TBL] [Abstract][Full Text] [Related]
36. The bronchodilator effect of NAB 365.
Kamburoff PL; Prime FJ; Schmidt OP
Br J Clin Pharmacol; 1977 Feb; 4(1):67-71. PubMed ID: 320990
[TBL] [Abstract][Full Text] [Related]
37. The effect of diet on the efficacy onset and duration of action of procaterol hydrochloride tablets.
Spangler DL; Lutz CN; Tinkelman D
Ann Allergy; 1987 Jan; 58(1):59-62. PubMed ID: 2948431
[TBL] [Abstract][Full Text] [Related]
38. Procaterol and terbutaline in bronchial asthma. A double-blind, placebo-controlled, cross-over study.
Dahl R; Harving H; Henriksen J; Rønne K; Schøler P
Allergy; 1985 Oct; 40(7):501-5. PubMed ID: 2933998
[TBL] [Abstract][Full Text] [Related]
39. Effect of inhaled procaterol hydrochloride in children with bronchial asthma, with particular reference to duration of effect.
Mitsuhashi M; Kimura T; Tateno K; Morikawa A; Kuroume T
J Asthma; 1985; 22(4):203-7. PubMed ID: 2931421
[TBL] [Abstract][Full Text] [Related]
40. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
